NSETrading Window1d ago · 23 Sept 2026, 07:58 pm
Trading Window
Themis Medicare Limited · THEMISMED
✦ AI Summary
Themis Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will be closed from 1st October, 2026 and will re-open after 48 hours from the declaration of un-audited financial results for the quarter and half year ending 30th September, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Themis Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
THEMISMED_23092026195821_ClosureofTWTML30092026.pdf
View document text
TML/BSE/NSE/2026-27/26 23rd September, 2026
Corporate Relationship Department Listing Department
BSE Limited National Stock Exchange of India Limited
Floor 25, Phiroze Jeejeebhoy Towers Exchange Plaza,
Dalal Street, Mumbai- 400001 Bandra Kurla Complex,
Scrip Code – 530199 Bandra (East), Mumbai- 400051
Symbol: THEMISMED
Dear Sir / Madam,
Re: - Intimation of closure of Trading Window in terms of SEBI (Prohibition of Insider Trading)
Regulations, 2015:
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and
Company’s Code of Conduct for prevention of Insider Trading, it is hereby notified that the
Trading Window i.e. period for trading in Company’s Shares / Securities will be closed with
effect from Thursday, 1st October, 2026 and will re-open after completion of 48 hours from the
declaration of un-audited financial results for the quarter and half year ending 30th
September, 2026 by the Board of Directors of the Company.
The date of Board Meeting for considering the said financial results for the quarter and half
year ending 30th September, 2026 will be intimated in due course.
We request you to kindly take this intimation on record.
Thanking you,
Yours faithfully
For Themis Medicare Limited
Dr. Dinesh S. Patel
Chairman
Themis Medicare Limited
Corporate Office: 11/12 Udyog Nagar, S V Road, Goregaon (W), Mumbai – 400 104, India
*Tel.: 91-22-67607080*Fax: 91-22-67607070/ 28746621
Regd. Office: Plot No. 69-A, G.I.D.C., Industrial Estate, Vapi-Gujarat
CIN No.: L24110GJ1969PLC001590 *Tel/ Fax No.: Regd. Off.: 0260-2431447/ 2430219
*E-mail: themis@themismedicare.com*Website: www.themismedicare.com